Recent advances in extracting phenolic compounds from food and their use in disease prevention and as cosmetics

R Dias, H Oliveira, I Fernandes… - Critical Reviews in …, 2021 - Taylor & Francis
Phenolic compounds in plants are essential components of human nutrition, which provide
various health benefits. However, some missing links became the research in phenolic …

Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities

L Yan, MS Guo, Y Zhang, L Yu, JM Wu… - Oxidative Medicine …, 2022 - Wiley Online Library
Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD),
and Huntington's disease (HD), are characterized by the progressive degeneration of …

Inhibition of the self-assembly of Aβ and of tau by polyphenols: Mechanistic studies

Q Zheng, MT Kebede, MM Kemeh, S Islam, B Lee… - Molecules, 2019 - mdpi.com
The amyloid-β (Aβ) peptide and tau protein are thought to play key neuropathogenic roles in
Alzheimer's disease (AD). Both Aβ and tau self-assemble to form the two major pathological …

Recent progress in research on mechanisms of action of natural products against Alzheimer's disease: Dietary plant polyphenols

Y Wang, K Wang, J Yan, Q Zhou, X Wang - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) is an incurable degenerative disease of the central nervous
system and the most common type of dementia in the elderly. Despite years of extensive …

Unraveling the therapeutic efficacy of resveratrol in Alzheimer's disease: an umbrella review of systematic evidence

A Azargoonjahromi, F Abutalebian - Nutrition & Metabolism, 2024 - Springer
Context Resveratrol (RV), a natural compound found in grapes, berries, and peanuts, has
been extensively studied for its potential in treating Alzheimer's disease (AD). RV has shown …

Inhibition of insulin degrading enzyme to control diabetes mellitus and its applications on some other chronic disease: A critical review

MS Azam, M Wahiduzzaman… - Pharmaceutical …, 2022 - Springer
Purpose This review aims to provide a precise perceptive of the insulin-degrading enzyme
(IDE) and its relationship to type 2 diabetes (T2D), Alzheimer's disease (AD), obesity, and …

Modulation of the Activity of the Insulin-Degrading Enzyme by Aβ Peptides

MM Kemeh, ND Lazo - ACS Chemical Neuroscience, 2023 - ACS Publications
The insulin-degrading enzyme (IDE) is an evolutionarily conserved protease implicated in
the degradation of insulin and amyloidogenic peptides. Most of the biochemical and …

Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease

S Chib, BJ Dutta, R Chalotra, M Abubakar… - Phytotherapy …, 2024 - Wiley Online Library
With the passage of time, people step toward old age and become more prone to several
diseases associated with the age. One such is Alzheimer's disease (AD) which results into …

Current and emerging pharmacological targets for the treatment of Alzheimer's disease

A Morsy, PC Trippier - Journal of Alzheimer's Disease, 2019 - content.iospress.com
No cure or disease-modifying therapy for Alzheimer's disease (AD) has yet been realized.
However, a multitude of pharmacological targets have been identified for possible …

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design

GR Tundo, G Grasso, M Persico, O Tkachuk, F Bellia… - Biomolecules, 2023 - mdpi.com
The insulin-degrading enzyme (IDE) is a Zn2+ peptidase originally discovered as the main
enzyme involved in the degradation of insulin and other amyloidogenic peptides, such as …